Cargando…
Severe Lymphopenia as a Predictor of COVID-19 Mortality in Immunosuppressed Patients
Background. Coronavirus disease 2019 (COVID-19) has a high mortality in certain group of patients. We analysed the impact of baseline immunosuppression in COVID-19 mortality and the role of severe lymphopenia in immunocompromised subjects. Methods. We analysed all patients admitted with COVID-19 in...
Autores principales: | Martínez-Urbistondo, María, Gutiérrez-Rojas, Ángela, Andrés, Ane, Gutiérrez, Isabel, Escudero, Gabriela, García, Sonia, Gutiérrez, Andrea, Sánchez, Enrique, Herráiz, Jesús, De La Fuente, Sara, Callejas, Alejandro, De Mendoza, Carmen, Moreno-Torres, Víctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396991/ https://www.ncbi.nlm.nih.gov/pubmed/34441891 http://dx.doi.org/10.3390/jcm10163595 |
Ejemplares similares
-
Bacterial infections in patients hospitalized with COVID-19
por: Moreno-Torres, Víctor, et al.
Publicado: (2021) -
Lymphopenia assessment in ICU patients and relationship with mortality
por: Gutierrez-Rodriguez, R, et al.
Publicado: (2015) -
Immunosuppressants: Lymphopenia and thrombocytopenia: 5 case reports
Publicado: (2021) -
Lymphopenia as a predictor of bacteremia in the emergency department
por: Lowsby, R, et al.
Publicado: (2014) -
Immunological Predictors of Dimethyl Fumarate‐Induced Lymphopenia
por: Diebold, Martin, et al.
Publicado: (2022)